De Wit S et al. |
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. |
1993 |
Lancet |
pmid:8093299
|
Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
Hakkarinen WD |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482929
|
Luger SW |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482930
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Lazard T et al. |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215285
|
Pialoux G et al. |
Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection. |
1993 |
Clin. Infect. Dis. |
pmid:8218702
|
Chien SM et al. |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. |
1993 |
Chest |
pmid:8449054
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Macklin JL et al. |
A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections. |
1993 |
J Chemother |
pmid:8371127
|
Ragnaud JM et al. |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania]. |
1993 |
Presse Med |
pmid:8378280
|
Hoffner SE et al. |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8392308
|
Gevaudan MJ et al. |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex. |
1993 |
J. Antimicrob. Chemother. |
pmid:8392998
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
Mazzei T et al. |
Chemistry and mode of action of macrolides. |
1993 |
J. Antimicrob. Chemother. |
pmid:7683018
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|
Holdcroft C |
Two new macrolide antibiotics: clarithromycin and azithromycin. |
1993 |
Nurse Pract |
pmid:8380492
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|